Cell-mediated immunity in children with Hodgkin's and non-Hodgkin's lymphomas

Pediatr Hematol Oncol. 1991 Jul-Sep;8(3):251-6. doi: 10.3109/08880019109033459.

Abstract

Natural killer (NK) cell activity and lymphocyte proliferation to mitogens might to have diagnostic implications that will help to distinguish between benign and malignant lymphadenopathy in children. In addition, we suggest that NK activity and especially the lowering of NK activity after chemotherapy might be of prognostic value in NHL children.

MeSH terms

  • Child
  • Hodgkin Disease / immunology*
  • Hodgkin Disease / mortality
  • Hodgkin Disease / pathology
  • Humans
  • Killer Cells, Natural / immunology*
  • Lymphocyte Activation*
  • Lymphoma, Non-Hodgkin / immunology*
  • Lymphoma, Non-Hodgkin / mortality
  • Lymphoma, Non-Hodgkin / pathology
  • Neoplasm Staging
  • Survival Rate